Headache in patients with systemic lupus erythematosus: A matched case-control study.

 0 Người đánh giá. Xếp hạng trung bình 0

Tác giả: Henrique de Ataíde Mariz, Bruno Rodrigo de Fontes, Igor de Oliveira, Angela Luzia Branco Pinto Duarte, Pedro Augusto Sampaio Rocha-Filho

Ngôn ngữ: eng

Ký hiệu phân loại:

Thông tin xuất bản: United States : Headache , 2025

Mô tả vật lý:

Bộ sưu tập: NCBI

ID: 734850

 OBJECTIVES: To compare the prevalence and characteristics of headaches between patients with systemic lupus erythematosus (SLE) and people without the disease and to assess whether there was a relationship between headaches and disease activity. BACKGROUND: Headache is a common symptom in patients with SLE
  however, the effect of SLE on headaches is not fully known. METHODS: This was a case-control study. Individuals with and without SLE matched by age and sex were compared. All participants were assessed by a neurologist. A semi-structured questionnaire, the six-item Headache Impact Test (HIT-6) and the Hospital Anxiety and Depression Scale were used. Disease activity was measured by a rheumatologist using the Physician Global Assessment (PGA) and quantified using the modified Systemic Lupus Erythematosus Disease Activity Index 2000 scale (modified SLEDAI-2K). Data were collected between November 2021 and January 2023. RESULTS: A total of 228 individuals were included, 114 in each group. The SLE group presented with more moderate/severe headache attacks than the controls (odds ratio [OR] 2.45, 95% confidence interval [CI] 1.21-4.95
  p = 0.013). When comparing patients with active SLE and those without disease activity, there was no difference in the prevalence (OR 1.48, 95% CI 0.38-5.74), type (migraine: OR 1.69, 95% CI 0.71-3.99
  tension-type headache: OR 0.64, 95% CI 0.25-1.68), frequency (4
  2-15 vs. 3
  1-12 days/month
  p = 0.250), intensity (moderate/severe intensity: OR 0.59, 95% CI 0.19-1.82), or impact of headache (HIT-6: 61
  50-65 vs. 56
  45-63
  p = 0.278). The magnitude of SLE activity (modified SLEDAI-2K) demonstrated no statistically significant association with the impact (standardized beta coefficient: 0.02, 95% CI -0.05 to 0.09
  p = 0.792) or monthly frequency of headache (standardized beta coefficient: 0.09, 95% CI -0.08 to 0.26
  p = 0.275). CONCLUSIONS: Headache is a common symptom in SLE, although the prevalence was similar to that of the controls without the disease. While patients with SLE had more intense headache attacks than the controls without SLE, there was no association between headache and SLE activity.
Tạo bộ sưu tập với mã QR

THƯ VIỆN - TRƯỜNG ĐẠI HỌC CÔNG NGHỆ TP.HCM

ĐT: (028) 36225755 | Email: tt.thuvien@hutech.edu.vn

Copyright @2024 THƯ VIỆN HUTECH